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Abstract
Obesity and its related pathologies are well- known health hazards. Although obesity and overweight have multifactorial 
causes, overeating is common in both of these conditions. According to animal models, endocannabinoids and their receptors 
in the brain play a key role in the genesis and development of obesity. It has been proposed that the cannabinoid receptors 
CB1 (RCB1) expressed in the nucleus accumbens shell (NAC) are involved in the increase of the hedonic properties of food. 
To test this hypothesis, this study aimed to assess the effects of activating the NACs RCB1 on standard food intake during the 
light phase of the light-dark cycle. The effects of activating the RCB1 with CP 55,940 and WIN 55-212-2 (0.125, 0.25 and 
0.5 nmol) in the NACS on feeding behavior and the behavioral satiety sequence of rats were assessed. It was found that both 
agonists increased food intake and delayed expression of satiety during the light phase. These results suggest that cannabinoid 
agonists encourage food intake when motivation is low and palatability is normal. 
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EFECTOS DE LA ACTIVACIÓN DEL RECEPTOR CANNABINOIDE CB1  
EN EL NÚCLEO ACCUMBENS SHELL SOBRE LA CONDUCTA ALIMENTARIA
Resumen
La obesidad y sus patologías relacionadas son riesgos de salud muy conocidos. Aunque la obesidad y el sobrepeso tienen 
causas multifactoriales, la sobreingesta de alimento es frecuente en estas condiciones. De acuerdo con modelos animales, 
los endocanabinoides y sus receptores en el cerebro juegan un papel clave en la génesis y desarrollo de la obesidad. Se 
ha propuesto que los receptores a canabinoides CB1 (RCB1) expresados en el núcleo accumbens shell (NAcS) están 
involucrados en el incremento de las propiedades hedónicas del alimento. Para probar esta hipótesis, este estudio tuvo 
como objetivo evaluar los efectos de la activación de los RCB1 en el NAcS sobre la ingesta de alimento estándar durante la 
fase de luz del ciclo luz-oscuridad. Se evaluaron los efectos de la activación de los RCB1 con WIN 55-212-2 y CP 55,940 
(0.125, 0.25, y 0.5 nmol) en el NAcS sobre la conducta alimentaria y la secuencia de saciedad conductual en ratas. Se 
encontró que ambos agonistas aumentaron la ingesta de alimento y demoraron la expresión de la saciedad durante la fase 
de luz. Lo anterior sugiere que los agonistas canabinoides estimulan el consumo de alimento cuando la motivación por el 
mismo es baja y la palatabilidad es normal.
Palabras clave: Canabinoides, alimentación, núcleo accumbens shell, secuencia de saciedad conductual.
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EFEITOS DA ATIVAÇÃO DO RECEPTOR CANNABINÓIDE CB1 NO NÚCLEO 
ACCUMBENS SHELL SOBRE A CONDUTA ALIMENTAR
Resumo
A obesidade e suas patologias relacionadas são riscos de saúde muito conhecidos. Ainda que a obesidade e o sobrepeso 
possuam causas multifatoriais, a sobre ingestão de alimento é frequente nestas condições. De acordo com modelos animais, 
os endocanabinóides e seus receptores no cérebro jogam um papel chave na gênese e desenvolvimento da obesidade. Foi 
proposto que os receptores a canabinóides CB1 (RCB1) expressos no núcleo accumbens shell (NAcS) estão envolvidos no 
aumento das propriedades hedônicas do alimento. Para testar esta hipótese, este estudo teve como objetivo avaliar os efeitos da 
ativação dos RCB1 nos NAcS sobre a ingestão de alimento padrão durante a fase de luz do ciclo luz-escuridão. Avaliaram-se 
os efeitos da ativação dos RCB1 com WIN 55-212-2 e CP 55,940 (0.125, 0.25, e 0.5 nmol) no NAcS sobre a conduta alimentar 
e a sequência de saciedade condutual em ratos. Encontrou-se que ambos agonistas aumentaram a ingestão de alimento e 
demoraram a expressão da saciedade durante a fase de luz. Isso sugere que os agonistas canabinóides estimulam o consumo 
de alimento quando a motivação pelo mesmo é baixa e a palatabilidade é normal.
Palavras chave: Canabinóides, alimentação, núcleo accumbens shell, sequência de saciedade conductual.
Obesity and its related pathologies are well-known health 
threats. Despite obesity and overweight have multifactorial 
causes, recurrent over-consumption of energy dense foods 
is frequently present in these conditions. Those diets are 
commonly highly palatable and may activate the brain 
reward circuit (Bassareo & Di Chiara, 1999; Mellis, et al., 
2007), promoting over-consumption when these foods are 
freely available (Perello, Chuang, Scott & Lutter, 2010) or 
with limited access schedules (Berner, Avena & Hoebel, 
2008; Dimitriou, Rice & Corwin, 2000). 
The nucleus accumbens shell (NAcS) plays a key role 
in processing the rewarding properties of stimuli, and sev-
eral neurochemical signaling pathways interact to regulate 
dopamine release in the NAcS and contribute to provide 
rewarding and/or hedonic properties to food (Gardner, 
2005). The endocannabinoid system has been implicated 
in reward-driven feeding (Matias, Cristino & Di Marzo, 
2008), and interestingly cannabinoid receptor 1 (CB1R) KO 
mice are resistant to diet-induced obesity, indicating that 
energy dense foods require endocannabinoid signaling to 
generate obesity (Quarta, et al., 2010). The experimental 
evidence indicates that the acute activation of CB1R in the 
NAcS by administration of anandamide (Soria-Gómez, et 
al., 2007) or 2-AG (Kirkham, Williams, Fezza & Di Marzo, 
2002) consistently stimulates chow intake.
Previous results in our laboratory showed that activation 
of CB1R in the paraventricular nucleus of the hypothalamus 
prevented the natural satiety sequence by modulating homeo-
static mechanisms (Escartín-Pérez, et al., 2009); nevertheless 
activation of cannabinoid receptors in the NAcS might also 
stimulate feeding by a different mechanism, for instance 
stimulating the hedonically positive sensory properties of 
food. Accordingly, the present study was aimed to evaluate 
the effects of activation of CB1R in the NAcS on feeding 
behavior using the behavioral satiety sequence (BSS) analy-
sis. It is hypothesized that acute activation of CB1R in the 
NAcS will stimulate feeding when a standard chow food 
is offered during the light phase of the photoperiod, when 
the basal food intake is naturally low and the hedonically 




A total of 38 male Wistar rats (UNAM, FESI México) 
weighting 220-240 g at the beginning sessions were used. 
Rats were housed in clear plastic cages with an inverted 
12x12 h light and dark cycle with standard food (LabDiet® 
formulab diet #5008) and water ad libitum. All experimen-
tal procedures complied with the Official Mexican Norm 
(NOM-062-ZOO-1999), entitled Technical Specifications 
for the Production, Care, and Use of Laboratory Animals.
Instruments and materials
Drugs and treatments. CP 55 940 (non-selective CB1R 
agonist) and WIN 55 212-2 (non-selective CB1R agonist) 
(Tocris Cookson Inc., Ellisville, MO, USA). Both drugs 
were dissolved in DMSO, Tween-80 and 0.9 % saline 
solution (4:2:94 v/v/v). Different doses of drugs were 
administered intra-NAcS according to the experimental 
design in a volume of 0.5 μl at 0.2 μl/min. Fresh solutions 
of drugs were prepared before the injections.
Behavioral test (food intake and behavioral satiety 
sequence). Consumption of standard chow (g) was as-
sessed in two independent periods of 60 min each (hour 1, 
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hour 2), 10 and 70 min post injection. The analysis of the 
BSS was conducted in both 60 min observation periods, 
which were divided in 12 segments (5 min bins). The 
duration (s) of each behavior was measured from the 
videotape recording to the following mutually exclusive 
categories: Intake (standard food), resting (inactivity with 
or without closed eyes, head of the rat was on the cage 
floor), activity (any other behavior different to feeding, 
resting, and grooming including locomotion, smelling, 
sniffing, etc), and grooming (self-cleaning of any part 
of the body). Durations of each behavioral category are 
presented in terms of duration (±SEM) over 12 periods 
(5-min bins) per hour, and served as the measure of the 
progression of BSS (Escartín-Pérez, et al., 2009).
Histology. After the behavioral tests, rats were given 
a lethal dose of sodium pentobarbital and were beheaded, 
brains were removed and fixed in 10% formalin for two 
days. Brains were sectioned at 100 μm in the coronal 
plane, and then positions of the cannulas and injection 
sites were verified. Brains in which drugs were not ad-
ministered in the NAcS were excluded from the present 
report (Figure 1).
Figure 1. Schematic representation of injection sites (black circles, 
left) in the NAcS.
 
Procedure
Surgery. All animals were anaesthetized with ketamine 
and xilasine (112.5 mg/kg and 22.5 mg/kg I.P.) and were 
stereotaxically implanted (unilaterally) with guide cannulas 
for injection in the nucleus accumbens shell (coordinates 
AP +1.52 mm and ML -0.7 mm relative to bregma, DV 
-6.0 mm relative to dura mater) according to Paxinos and 
Watson’s Atlas (1998). After surgery, animals were admin-
istered with benzathine penicillin (300,000 UI/kg, I.M.) 
and they had a surgical recovery period of five days with 
food and water ad libitum.
Design and recordings. After the surgical recovery 
period, animals were randomly assigned to independent 
groups that received vehicle or different intra-NAcS treat-
ments of WIN 55 212-2 (0.125, 0.25, 0.5 nmol) or CP 55 
940 (0.125, 0.25, 0.5 nmol) and behavioral recordings were 
conducted. Immediately after central injections, animals 
were placed into their home cages with pre-weighted stan-
dard chow; behavior was video-recorded and subsequently 
measured to obtain the BSS during two consecutive hours 
(two recordings of 60 min each, hour 1 and hour 2). At the 
end of the observations, food containers were removed 
and ingestion of food was calculated (g). Animals were 
individually housed with food and water ad libitum. All 
behavioral observations were conducted during the light 
phase of the light/dark cycle.
Statistical analysis. Analyses of data from food intake 
measurements were performed by two-way ANOVAs (dose 
x hour) to calculate significance of the differences by intra-
NAcS injections. When appropriate, the Bonferroni’s test 
was performed. The criterion for statistical significance 
was p < 0.05. Data were analyzed using GraphPad Prism 
Version 5.0.
RESULTS
Data from standard food consumption measurements 
(g) and the BSS (s) are expressed as means (± SEM) and 
are organized in two independent sections: 1) Food intake, 
and 2) Behavioral satiety sequence (BSS) analyses.
Effects of cannabinoid receptors activation in the NAcS 
on food intake
Firstly, it was investigated if intra-NAcS activation of 
cannabinoid receptors with two different agonists produced 
significant changes in chow consumption in a situation 
where the basal intake is low (light phase of photoperiod). 
Consistent with reports that found a stimulatory effect of 
activation of CB1R in the nucleus accumbens, intra-NAcS 
injections of WIN 55 212-2 (all doses) significantly increased 





= 7.511; factor hour F
(1,30)
= 25.81;p< 0.05) 
during the first hour of observation, and the effect persisted 
during the second hour of the behavioral record when a 
dose of 0.25 nmol was administered (Figure 2).
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Figure 2. Effects of intra-NAcS injections of different doses of WIN 
55 212-2 (WIN) on standard chow intake during two behavioral re-
cords (hour 1 and hour 2). Data expressed in terms of means ± SEM. 
*p<0.05, ***p<0.001 vs vehicle group (Vh); n= 4-6 per group.
Independent groups of rats were administered with the 
non-selective cannabinoid receptor agonist, CP 55 940, 
at different doses. It was found that the activation of can-
nabinoid receptors in the NAcS (all doses of CP 55940) 
increased significantly standard chow intake (interaction 
dose x hour F
(3,30)
= 6.045 p<0.01; factor dose F
(3,30)
= 7.674 
p<0.001; factor hour F
(1,30)
= 54.66;p< 0.001) during the 
first hour. No statistically significant effect on the second 
period of observation was found (Figure 3).
Figure 3. Effects of intra-NAcS injections of different doses of CP 
55 940 (CP) on standard chow intake during 2 behavioral records 
(hour 1 and hour 2). Data expressed in terms of means ± SEM. 
***p<0.001 vs vehicle group; n= 4-6 per group.
Effects of cannabinoid receptors activation in the NAcS on 
the behavioral satiety sequence
In order to assess the behavioral profile associated to 
the stimulatory effect of intra-NAcS cannabinoid receptor 
activation on chow intake, the BSS in the same periods 
of time (hour 1 and hour 2) was analyzed. It was found 
that control animals began the test eating during the first 
periods, but subsequently the time spent eating decreased 
while the time of resting increased, showing the transition 
from eating to resting after the third period of the first hour 
of observation; activity and grooming remained low dur-
ing the complete test (hour 1 and hour 2). As expected, in 
the second hour, control animals spent time resting during 
almost the complete 60-min record, reflecting satiety (Fig. 
4. A, B). Animals treated with 0.125 and 0.25 nmol of WIN 
55 212-2 showed a delayed transition from eating to rest-
ing in the first hour of observation (6th and 7th periods, 
respectively), resting less time and with a higher level of 
activity (specially the 0.125 nmol dose) than control rats. 
During the second hour of observation, animals treated with 
the lower dose of WIN 55 212-2 (0.125 nmol) remained 
comparable to the control group; however, the 0.25 nmol 
dose induced new meals and a higher level of activity, 
preventing the increase of the resting time as observed 
in control animals (Figure 4. C, D, and E, F). Finally, the 
higher dose of WIN 55 212-2 did not alter the behavioral 
profile observed in the control group. Nevertheless, animals 
in this group spent more time eating during the beginning 
of the first hour (Figure 4. G, H).
The behavioral profile produced by intra-NAcS injec-
tions of CP 55 940 (0.125, 0.25 and 0.5 nmol) was also 
assessed and it was found that all doses consistently de-
layed the transition from eating to resting during the first 
hour of observation (after the 6th, 7th and 9th periods, 
respectively), with a corresponding increase on the time 
of activity (Figure 5. C, E, G). During the second hour of 
observation, the higher doses of CP 55 940 (0.25 and 0.5 
nmol) decreased the time spent resting (Figure 5. F, H), 
while the lower dose (0.125 nmol) remained similar to the 
control group (Figure 5. D).
DISCUSSION
The present study was aimed to test the hypothesis that 
acute activation of CB1R in the NAcS stimulate standard 
chow intake during the light phase of the photoperiod in 
rats maintained on ad libitum chow. It is shown here that 
both WIN 55 212-2 and CP 55 940 increase standard chow 
intake and delay the expression of the natural satiety se-
quence. According to the behavioral analyses carried out, 
intra-NAcS administration of CB1R agonists stimulates 
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Figure 4. Behavioral satiety sequence of groups injected with vehicle (A, B), or WIN 55 212-2 0.125 (C, D), 0.25 (E, F) and 0.5 (G, H) 
nmol. Values are presented as mean (error bars represent SEM) of duration of each behavioral category (intake, resting, activity and groo-
ming) during the two hours of the behavioral test (hour 1, hour 2). The vertical line (solid) indicates the moment in which the transition 
between intake and resting occurred; the vertical line (dotted) indicates that the transition between intake and resting occurred before the 
beginning of the second behavioral record, n= 4-6 per group.
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Figure 5. Behavioral satiety sequence of groups injected with vehicle (A, B), or CP 55 940 0.125 (C, D), 0.25 (E, F) and 0.5 (G, H) nmol. 
Values are presented as mean (error bars represent SEM) of duration of each behavioral category (intake, resting, activity and grooming) 
during the two hours of the behavioral test (hour 1, hour 2). The vertical line (solid) indicates the moment in which the transition between 
intake and resting occurred; the vertical line (dotted) indicates that the transition between intake and resting occurred before the beginning 
of the second behavioral record, n= 4-6 per group.
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feeding during the light phase of the photoperiod, when 
the basal intake is naturally low, suggesting that canna-
binoid agonists consistently stimulate food consumption 
when motivation for food is low and palatability is regular 
(standard chow).
Different studies have explored the role of cannabi-
noid receptors in the hypothalamus (Verty, McGregor & 
Mallet, 2005; Jamshidy & Taylor, 2001), indicating that 
the stimulatory effect of cannabinoids is related to the 
homeostatic modulation of food intake. Furthermore, be-
havioral experiments have shown that rimonabant bilaterally 
microinjected into the NAcS selectively decreased highly 
palatable food intake in an operant task (Guegan, et al., 
2013). Our results confirm and extend the previous evidence 
that intra-accumbens administration of anandamide or 2-AG 
increase standard chow consumption (Soria-Gómez, et 
al., 2007; Kirkham, et al., 2002) by a behavioral-specific 
mechanism. Taking together these findings, it seems pos-
sible that cannabinoid receptors modulate feeding behavior 
simultaneously by two independent processes; the first one, 
homeostatic, characterized by affecting energy balance and 
motivational processes (hunger, appetite, satiety) (Cota, et 
al., 2003; Escartín-Pérez, et al., 2009); and the second one, 
hedonic, increasing the rewarding properties of food and 
its hedonically positive sensory properties (Di Patrizio & 
Simansky, 2008).
Despite the fact that the lower doses of WIN 55 
212-2 (0.125 and 0.5 nmol) and all doses of CP 55 940 
increased the time of activity (especially in the first hour 
of observation), this effect did not disrupt the behavioral 
profile associated to post-ingestive satiety sequence ei-
ther the transition from eating to resting, suggesting that 
the endocannabinoid system in this particular conditions 
promotes feeding and increases motor activity. It is well 
know that cannabinoids affect motor behavior via CB1R 
by regulating glutamatergic and GABAergic transmission 
(González, et al., 2009). Specifically, cannabinoid recep-
tors located in basal ganglia modulate both the inhibi-
tory and the excitatory neuronal transmission, providing 
regulation of movement (Sanudo-Pena, Patrick, Patrick 
& Walker, 1996). Several reports showed that systemic 
administration of the cannabinoid receptor agonist WIN 
55,212-2 stimulated locomotor activity in the open field 
test at low doses (0.25-0.6 mg/kg) (Pandolfo, Pamplona, 
Prediger & Takahashi, 2007; Drews, Schneider & Koch, 
2005) and this effect was described as a general motor 
stimulating effect. Nevertheless, in the present study both 
cannabinoid agonists were administered intra-NAcS and 
the behavioral profile elicited should not be considered 
as a general stimulating effect, since the endogenous can-
nabinoid system is strongly involved in the development 
of food-induced behavioral alterations, such as food-
seeking. Supporting this notion, it was demonstrated that 
the deletion of CB1R decreased operant behavior and the 
motivation to obtain highly palatable food in CB1 KO 
mice (Guegan, et al., 2013). Furthermore, the findings that 
CB1R KO rodents are resistant to diet-induced obesity 
(Ravinet-Trillou, Delgorge, Menet, Arnone & Soubrié, 
2004), and that over-activity of the endocannabinoid system 
promotes an obese phenotype (Maccarrone, et al., 2010), 
in conjunction with the cannabinoid-induced increase of 
activity observed in this study, suggest a functional con-
nection between the endocannabinoid system, ineffective 
inhibition of responses and obesity. Accordingly, chronic 
exposure to cannabinoid agonists should be studied in 
order to determine if the cannabinoid-induced increase of 
activity is related to the impulsivity observed in obesity 
(Nederkoorn, Braet, Van Eijs, Tanghe & Jansen, 2006).
In spite of the pharmacological lack of selectivity of 
WIN 55-212-2 and CP 55,940 at CB1 and CB2 receptors, 
there is no knowledge of reports of CB2 expression in the 
NAcS. Only multifocal expression of CB2 immunoreactiv-
ity has been reported in different areas of rodent brains at 
levels much lower than those of CB1 receptors (cerebellum, 
hippocampus, olfactory tubercle, cerebral cortex, thalamus, 
amygdala, basal ganglia, periaqueductal gray) (Gong, et al., 
2006). Nevertheless, conclusive pharmacological evidence 
of the CB1R participation in the reported effects should be 
provided (i.e. administering selective antagonists).
In summary, activation of CB1 receptors in the nucleus 
accumbens shell stimulates standard chow intake during the 
light phase of the photoperiod, when the basal food intake is 
naturally low and the hedonically positive sensory properties 
of food may be stimulated. Further research should explore 
in detail the relationship between the endocannabinoid 
system, impulsivity, and obesity.
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